CN105497585A - Myopia treating traditional Chinese medicine formula - Google Patents
Myopia treating traditional Chinese medicine formula Download PDFInfo
- Publication number
- CN105497585A CN105497585A CN201410489382.9A CN201410489382A CN105497585A CN 105497585 A CN105497585 A CN 105497585A CN 201410489382 A CN201410489382 A CN 201410489382A CN 105497585 A CN105497585 A CN 105497585A
- Authority
- CN
- China
- Prior art keywords
- fructus
- radix
- chinese medicine
- myopia
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a myopia treating traditional Chinese medicine formula, belongs to the technical field of traditional Chinese medicines, and particularly relates to a myopia treating traditional Chinese medicine formula. The present invention provides a formula of a myopia treating traditional Chinese medicine with characteristics of significant treatment effect and patient symptom eliminating, wherein the myopia treating traditional Chinese medicine is prepared from the following raw materials: fructus ligustri lucidi, tropaeolum majus, common yam rhizome, radix adenophorae, forsythia suspensa seed, rubus chingii, tuckahoe, ophiopogon japonicus, tribulus terrestris l, lophatherum gracile, plantaginis semen, fructus leonuri, milkvetch root, semen cassiae, Chinese wolfberry, mother of pearl, white paper, flos eriocauli, ligusticum chuanxiong hort, atractylodes macrocephala, and licorice root.
Description
Technical field
The invention belongs to technical field of Chinese medicines, particularly relate to a kind of Chinese medicine formula for the treatment of myopia.
Background technology
Eyes are one of most important sensory organ of human body, and myopia is that common ophthalmology takes a disease.Myopia disease has the multiple origin cause of formation, such as, due to by the bad myopia caused of eye mode, due to the myopia that heredity causes, due to drug-induced myopia etc.Myope has blurring of vision symptom usually; Have the patient of other ophthalmics, also have that order is dark, blurred vision, conjunctival congestion, many tear, the symptom such as to hide from view.
Myopia is that myopia refers to that eye is when not adjustment in use, parallel rays by after the dioptric system flexion of eye, focus drop on retina before a kind of refractive status.So myopia can not see the target in a distant place clearly, if target to be shifted near to eye gradually, the light that sends in scattering to a certain degree to eye, forms focus and just move backward, when object shift near at the moment certain a bit.This position from eye more close to, bathomorphic degree is darker.
Summary of the invention
The present invention is exactly for the problems referred to above, provides a kind of evident in efficacy, the Chinese medicine formula of the treatment myopia that patient can be made symptomatolytic.
For achieving the above object, the present invention is made up of following raw materials according: Fructus Ligustri Lucidi, Herba Tropaeoli, Rhizoma Dioscoreae, Radix Adenophorae, golden bell core, Fructus Rubi, Poria, Radix Ophiopogonis, Fructus Tribuli, Herba Lophatheri, Semen Plantaginis, Fructus Leonuri, the Radix Astragali, Semen Cassiae, Fructus Lycii, Concha Margaritifera, blank sheet of paper, Flos Eriocauli, Rhizoma Chuanxiong, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae.
As a kind of preferred version, Fructus Ligustri Lucidi of the present invention, Herba Tropaeoli, Rhizoma Dioscoreae, Radix Adenophorae, golden bell core, Fructus Rubi, Poria, Radix Ophiopogonis, Fructus Tribuli, Herba Lophatheri, Semen Plantaginis, Fructus Leonuri, the Radix Astragali, Semen Cassiae, Fructus Lycii, Concha Margaritifera, blank sheet of paper, Flos Eriocauli, Rhizoma Chuanxiong, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae weight portion is: Fructus Ligustri Lucidi 60-120, Herba Tropaeoli 40-80, Rhizoma Dioscoreae 35-80, Radix Adenophorae 40-80, golden bell core 60-120, Fructus Rubi 70-150, Poria 35-80, Radix Ophiopogonis 35-80, Fructus Tribuli 70-150, Herba Lophatheri 35-80, Semen Plantaginis 40-80, Fructus Leonuri 60-120, Radix Astragali 40-80, Semen Cassiae 40-80, Fructus Lycii 40-80, Concha Margaritifera 70-150, blank sheet of paper 60-120, Flos Eriocauli 40-80, Rhizoma Chuanxiong 40-80, Rhizoma Atractylodis Macrocephalae 35-80, Radix Glycyrrhizae 60-120.
As another kind of preferred version, Fructus Ligustri Lucidi of the present invention, Herba Tropaeoli, Rhizoma Dioscoreae, Radix Adenophorae, golden bell core, Fructus Rubi, Poria, Radix Ophiopogonis, Fructus Tribuli, Herba Lophatheri, Semen Plantaginis, Fructus Leonuri, the Radix Astragali, Semen Cassiae, Fructus Lycii, Concha Margaritifera, blank sheet of paper, Flos Eriocauli, Rhizoma Chuanxiong, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae weight portion is: Fructus Ligustri Lucidi 60, Herba Tropaeoli 80, Rhizoma Dioscoreae 35, Radix Adenophorae 80, golden bell core 60, Fructus Rubi 150, Poria 35, Radix Ophiopogonis 35, Fructus Tribuli 150, Herba Lophatheri 80, Semen Plantaginis 80, Fructus Leonuri 60, the Radix Astragali 80, Semen Cassiae 80, Fructus Lycii 40, Concha Margaritifera 150, blank sheet of paper 60, Flos Eriocauli 80, Rhizoma Chuanxiong 80, the Rhizoma Atractylodis Macrocephalae 35, Radix Glycyrrhizae 120.
In addition, raw material of the present invention also comprises weight portion and is: Radix Salviae Miltiorrhizae 50, Radix Codonopsis 45, Radix Puerariae 35, Semen Cuscutae 40.
Beneficial effect of the present invention.
Radix Codonopsis of the present invention, the Radix Astragali, Radix Glycyrrhizae have than spleen QI invigorating, the effects such as the spleen strengthening and damp drying, Rhizoma Chuanxiong have invigorate blood circulation, enrich blood, nourish blood, the effect of removing blood stasis to reduce swelling, again can be complementary with Qi-tonifying drug, Radix Puerariae can improve fundus microcirculation, spasmolytic, granulation promoting, the Radix Angelicae Dahuricae, Concha Margaritifera and Fructus Atriplicis Sibiricae have stimulates verse neural excitation, dredging eyeball, and soothing the channels and quicking the network vessels, removes asthenopic effect.The Chinese medicine for the treatment of myopia eye diseases of the present invention, also or can make powder or add compressed with adhesive to become tablet or make pill by agitation procedure or add implant to make electuary etc. and make product by conventional method.The capsule usage of Chinese medicine of the present invention is oral, warm water delivery service, every day 3 times, each 2 ~ 3.The Chinese medicine result in clinical application for the treatment of myopia eye diseases of the present invention shows, this prescription have liver heat removing nourishing the liver, improving kidney and eyes, dispel the wind, spasmolytic, promotion visual cell generate effect, optic nerve, retina cell reparation can be promoted, reinforcing glass body steadiness, prevention retina shedding, be used for the treatment of the myopia, asthenopia etc. that a variety of causes causes to take a disease, formula is unique, and curative effect is also unique, especially to child and juvenile patient, evident in efficacy, patient can be made to eliminate symptom, recover vision.
Detailed description of the invention
The present invention is made up of following raw materials according: Fructus Ligustri Lucidi, Herba Tropaeoli, Rhizoma Dioscoreae, Radix Adenophorae, golden bell core, Fructus Rubi, Poria, Radix Ophiopogonis, Fructus Tribuli, Herba Lophatheri, Semen Plantaginis, Fructus Leonuri, the Radix Astragali, Semen Cassiae, Fructus Lycii, Concha Margaritifera, blank sheet of paper, Flos Eriocauli, Rhizoma Chuanxiong, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae.
Described Fructus Ligustri Lucidi, Herba Tropaeoli, Rhizoma Dioscoreae, Radix Adenophorae, golden bell core, Fructus Rubi, Poria, Radix Ophiopogonis, Fructus Tribuli, Herba Lophatheri, Semen Plantaginis, Fructus Leonuri, the Radix Astragali, Semen Cassiae, Fructus Lycii, Concha Margaritifera, blank sheet of paper, Flos Eriocauli, Rhizoma Chuanxiong, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae weight portion is: Fructus Ligustri Lucidi 60-120, Herba Tropaeoli 40-80, Rhizoma Dioscoreae 35-80, Radix Adenophorae 40-80, golden bell core 60-120, Fructus Rubi 70-150, Poria 35-80, Radix Ophiopogonis 35-80, Fructus Tribuli 70-150, Herba Lophatheri 35-80, Semen Plantaginis 40-80, Fructus Leonuri 60-120, Radix Astragali 40-80, Semen Cassiae 40-80, Fructus Lycii 40-80, Concha Margaritifera 70-150, blank sheet of paper 60-120, Flos Eriocauli 40-80, Rhizoma Chuanxiong 40-80, Rhizoma Atractylodis Macrocephalae 35-80, Radix Glycyrrhizae 60-120.
Described Fructus Ligustri Lucidi, Herba Tropaeoli, Rhizoma Dioscoreae, Radix Adenophorae, golden bell core, Fructus Rubi, Poria, Radix Ophiopogonis, Fructus Tribuli, Herba Lophatheri, Semen Plantaginis, Fructus Leonuri, the Radix Astragali, Semen Cassiae, Fructus Lycii, Concha Margaritifera, blank sheet of paper, Flos Eriocauli, Rhizoma Chuanxiong, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae weight portion is: Fructus Ligustri Lucidi 60, Herba Tropaeoli 80, Rhizoma Dioscoreae 35, Radix Adenophorae 80, golden bell core 60, Fructus Rubi 150, Poria 35, Radix Ophiopogonis 35, Fructus Tribuli 150, Herba Lophatheri 80, Semen Plantaginis 80, Fructus Leonuri 60, the Radix Astragali 80, Semen Cassiae 80, Fructus Lycii 40, Concha Margaritifera 150, blank sheet of paper 60, Flos Eriocauli 80, Rhizoma Chuanxiong 80, the Rhizoma Atractylodis Macrocephalae 35, Radix Glycyrrhizae 120.
Raw material of the present invention also comprises weight portion: Radix Salviae Miltiorrhizae 50, Radix Codonopsis 45, Radix Puerariae 35, Semen Cuscutae 40.
Embodiment gets Rhizoma Dioscoreae 122g and Poria 122g through cleaning, curing, be ground into fine powder, for subsequent use; Again the medicinal clear water of 14 taste such as Semen Cassiae 122g, Radix Salviae Miltiorrhizae 122g, Fructus Ligustri Lucidi 244g, Herba Tropaeoli 122g, Radix Adenophorae 122g, golden bell core 97g, Fructus Rubi 122g, Radix Ophiopogonis 122g, Fructus Tribuli 97g, Herba Lophatheri 73g, Semen Plantaginis 122g, Fructus Leonuri 97g, Radix Astragali 122g, Ramulus Uncariae Cum Uncis 97g is decocted, extract decoction liquor, carry out 3 times altogether, each decoction 1 hour; Then the decoction liquor will extracted filters, and gets that its filtrate steaming and decocting is concentrated makes extractum, then adds medicated powder for subsequent use, mixing; Dry by conventional method, pulverize, sieve, usually require that medicated powder fineness is at below 1mm, after the assay was approved, namely incapsulates, make capsule product.
Above content is the further description done the present invention in conjunction with concrete preferred implementation; can not assert that specific embodiment of the invention is confined to these explanations; for general technical staff of the technical field of the invention; without departing from the inventive concept of the premise; some simple deduction or replace can also be made, all should be considered as belonging to the protection domain that claims that the present invention submits to are determined.
Claims (4)
1.
treat a Chinese medicine formula for myopia, it is characterized in that being made up of following raw materials according: Fructus Ligustri Lucidi, Herba Tropaeoli, Rhizoma Dioscoreae, Radix Adenophorae, golden bell core, Fructus Rubi, Poria, Radix Ophiopogonis, Fructus Tribuli, Herba Lophatheri, Semen Plantaginis, Fructus Leonuri, the Radix Astragali, Semen Cassiae, Fructus Lycii, Concha Margaritifera, blank sheet of paper, Flos Eriocauli, Rhizoma Chuanxiong, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae.
2.
a kind of Chinese medicine formula for the treatment of myopia according to claim 1, it is characterized in that described Fructus Ligustri Lucidi, Herba Tropaeoli, Rhizoma Dioscoreae, Radix Adenophorae, golden bell core, Fructus Rubi, Poria, Radix Ophiopogonis, Fructus Tribuli, Herba Lophatheri, Semen Plantaginis, Fructus Leonuri, the Radix Astragali, Semen Cassiae, Fructus Lycii, Concha Margaritifera, blank sheet of paper, Flos Eriocauli, Rhizoma Chuanxiong, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae weight portion is: Fructus Ligustri Lucidi 60-120, Herba Tropaeoli 40-80, Rhizoma Dioscoreae 35-80, Radix Adenophorae 40-80, golden bell core 60-120, Fructus Rubi 70-150, Poria 35-80, Radix Ophiopogonis 35-80, Fructus Tribuli 70-150, Herba Lophatheri 35-80, Semen Plantaginis 40-80, Fructus Leonuri 60-120, Radix Astragali 40-80, Semen Cassiae 40-80, Fructus Lycii 40-80, Concha Margaritifera 70-150, blank sheet of paper 60-120, Flos Eriocauli 40-80, Rhizoma Chuanxiong 40-80, Rhizoma Atractylodis Macrocephalae 35-80, Radix Glycyrrhizae 60-120.
3.
a kind of Chinese medicine formula for the treatment of myopia according to claim 2, it is characterized in that described Fructus Ligustri Lucidi, Herba Tropaeoli, Rhizoma Dioscoreae, Radix Adenophorae, golden bell core, Fructus Rubi, Poria, Radix Ophiopogonis, Fructus Tribuli, Herba Lophatheri, Semen Plantaginis, Fructus Leonuri, the Radix Astragali, Semen Cassiae, Fructus Lycii, Concha Margaritifera, blank sheet of paper, Flos Eriocauli, Rhizoma Chuanxiong, the Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae weight portion is: Fructus Ligustri Lucidi 60, Herba Tropaeoli 80, Rhizoma Dioscoreae 35, Radix Adenophorae 80, golden bell core 60, Fructus Rubi 150, Poria 35, Radix Ophiopogonis 35, Fructus Tribuli 150, Herba Lophatheri 80, Semen Plantaginis 80, Fructus Leonuri 60, the Radix Astragali 80, Semen Cassiae 80, Fructus Lycii 40, Concha Margaritifera 150, blank sheet of paper 60, Flos Eriocauli 80, Rhizoma Chuanxiong 80, the Rhizoma Atractylodis Macrocephalae 35, Radix Glycyrrhizae 120.
4.
according to claim 3, treat a Chinese medicine formula for myopia, characterized by further comprising weight portion is: Radix Salviae Miltiorrhizae 50, Radix Codonopsis 45, Radix Puerariae 35, Semen Cuscutae 40.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410489382.9A CN105497585A (en) | 2014-09-24 | 2014-09-24 | Myopia treating traditional Chinese medicine formula |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410489382.9A CN105497585A (en) | 2014-09-24 | 2014-09-24 | Myopia treating traditional Chinese medicine formula |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105497585A true CN105497585A (en) | 2016-04-20 |
Family
ID=55706143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410489382.9A Pending CN105497585A (en) | 2014-09-24 | 2014-09-24 | Myopia treating traditional Chinese medicine formula |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105497585A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107929455A (en) * | 2017-12-26 | 2018-04-20 | 夏战利 | A kind of traditional Chinese medicine reagent prevented and mitigation is near-sighted |
| CN108404052A (en) * | 2018-05-09 | 2018-08-17 | 杜世东 | Prevention myopia, the pharmaceutical composition and the preparation method and application thereof of amblyopia |
-
2014
- 2014-09-24 CN CN201410489382.9A patent/CN105497585A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107929455A (en) * | 2017-12-26 | 2018-04-20 | 夏战利 | A kind of traditional Chinese medicine reagent prevented and mitigation is near-sighted |
| CN108404052A (en) * | 2018-05-09 | 2018-08-17 | 杜世东 | Prevention myopia, the pharmaceutical composition and the preparation method and application thereof of amblyopia |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101985001A (en) | Chinese herbal medicine for treating insomnia | |
| CN101559195A (en) | Epilepsy therapy capsule and preparation method thereof | |
| CN103223118B (en) | Traditional Chinese medicine composition for treating facial paralysis | |
| CN104258297A (en) | Traditional Chinese medicine for treating qi stagnation and blood stasis type viral myocarditis and preparation method of traditional Chinese medicine | |
| CN102000278B (en) | Traditional Chinese medicine for treating amblyopia eye diseases | |
| CN103735790A (en) | Traditional Chinese medicine composition for treating tinnitus | |
| CN103212021A (en) | Traditional Chinese medicine composition used for treating chloasma | |
| CN104352942A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN102670993B (en) | Traditional Chinese medicine for treating cataract | |
| CN105497585A (en) | Myopia treating traditional Chinese medicine formula | |
| CN102698093A (en) | Chinese medicinal composition for treating liver and kidney deficiency type hypertension and preparation method thereof | |
| CN102000279B (en) | Traditional Chinese medicine for treating myopia eye diseases | |
| CN103735899A (en) | Hypertension injection nursing drug and preparation method thereof | |
| CN103550549A (en) | Traditional Chinese medicine (TCM) composition for treating deficiency of heart-yin | |
| CN103316283B (en) | Traditional Chinese medicinal composition for treating chronic cholecystitis, and preparation method thereof | |
| CN102327442A (en) | Method for preparing traditional Chinese medicine (TCM) lotion for treating insomnia bedsore | |
| CN102327533A (en) | Chinese herbal medicine for treating earliest scrofula | |
| CN102327410B (en) | Traditional Chinese medicine composition for treating epigastric fullness | |
| CN104399042A (en) | Traditional Chinese medicine for treating intractable diaphragmatic muscle spasm and preparation method thereof | |
| CN110478442A (en) | A kind of Multifunctional eye drops and preparation method thereof | |
| CN103830513A (en) | Traditional Chinese medicine preparation for treating primary glaucoma | |
| CN1268354C (en) | Traditional Chinese medicine preparation for treating myopia and method for preparing the same | |
| CN102895550B (en) | Traditional Chinese medicine for treating glomerulonephritis | |
| CN102920884B (en) | Traditional Chinese medicine (TCM) for curing chronic prostatitis | |
| CN101264186A (en) | Forming method of Chinese medicine formula for preventing and controlling dizziness and its preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160420 |